siRNA-Mediated Silencing of CIP2A Enhances Docetaxel Activity Against PC-3 Prostate Cancer Cells

• Main Authors: Saiedeh Razi Soofiyani (Author), Akbar Mohammad Hoseini (Author), Ali Mohammadi (Author), Vahid Khaze Shahgoli (Author), Behzad Baradaran (Author), Mohammad Saeid Hejazi (Author)
• Format: Book
• Published: Tabriz University of Medical Sciences, 2017-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Purpose: Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an identified human oncoprotein which modulates malignant cell growth. It is overexpressed in human prostate cancer and in most of the human malignancies. The aim of this study was to investigate the effects of CIP2A silencing on the...